Consensus Aveanna Healthcare Holdings Inc.

Equities

AVAH

US05356F1057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
2.16 ^USD	-2.70%		-10.00%	-19.40%

Apr. 03	Aveanna Healthcare Holdings Inc Announces Appointment of Jerry Perchik to Serve as Chief Legal Officer and Secretary, Effective April 29, 2024	CI
Mar. 18	Deutsche Bank Adjusts Aveanna Healthcare Price Target to $3 From $2, Maintains Buy Rating	MT

Evolution of the average Target Price on Aveanna Healthcare Holdings Inc.

Price target over the last 5 years

History of analyst recommendation changes

b.IJiltMyKpecehnhajJTUUfdTNxDBe1F1MLFSMPB3Zqw.TvLhjIncxI5btyk45eOaC7g7eVfwERtMfvQBCKcUNZRz_uDerdDzo3-wFw~3c739beb2c62f69b342291948934149f

Analyst Recommendations on Aveanna Healthcare Holdings Inc.

Deutsche Bank Adjusts Aveanna Healthcare Price Target to $3 From $2, Maintains Buy Rating	Mar. 18	MT
JPMorgan Downgrades Aveanna Healthcare to Underweight From Neutral	Dec. 13	MT
UBS Initiates Coverage on Aveanna Healthcare With Sell Rating, $1.50 Price Target	Nov. 30	MT
Deutsche Bank Adjusts Aveanna Healthcare Price Target to $2 From $1.70, Maintains Buy Rating	23-08-14	MT
RBC Boosts Price Target on Aveanna Healthcare Holdings to $3 From $2 After 'Solid' Q2 Results, Keeps Sector Perform Rating	23-08-14	MT
Truist Securities Adjusts Aveanna Healthcare Price Target to $1.70 From $1.40, Maintains Hold Rating	23-07-13	MT
Raymond James Downgrades Aveanna Healthcare Holdings to Market Perform From Strong Buy	23-05-12	MT
Aveanna Healthcare Receives Price Target Cut to $2 From $3 From RBC as 2023 EBITDA View Disappoints; Sector Perform Kept	23-03-20	MT
Raymond James Adjusts Price Target on Aveanna Healthcare to $3 From $4, Keeps Strong Buy Rating	23-03-20	MT
Truist Securities Adjusts Price Target on Aveanna Healthcare Holdings to $1.40 From $1, Maintains Hold Rating	23-03-17	MT
Deutsche Bank Lowers Price Target on Aveanna Healthcare to $1.70 From $3, Keeps Buy Rating	23-03-17	MT
Credit Suisse Downgrades Aveanna Healthcare Holdings to Underperform From Neutral, Notes High Leverage, Uncertain Timing of Turnaround; Trims PT to $1 From $2	23-01-27	MT
RBC Capital Downgrades Aveanna Healthcare Holdings to Sector Perform From Outperform, Adjusts Price Target to $3 From $7	22-11-21	MT
Credit Suisse Downgrades Aveanna Healthcare Holdings to Neutral From Outperform Given Debt Levels, Cuts PT to $2 From $5.50	22-11-17	MT
Raymond James Adjusts Price Target on Aveanna Healthcare Holdings to $4 From $6, Maintains Strong Buy Rating	22-11-16	MT
Stephens Adjusts Price Target on Aveanna Healthcare Holdings to $1.50 From $2.25, Maintains Equal-Weight Rating	22-11-11	MT
Barclays Adjusts Price Target on Aveanna Healthcare Holdings to $5 From $7, Reiterates Overweight Rating	22-08-19	MT
Raymond James Adjusts Price Target on Aveanna Healthcare Holdings to $6 From $8, Reiterates Strong Buy Rating	22-08-15	MT
Deutsche Bank Adjusts Price Target on Aveanna Healthcare Holdings to $3 From $6, Maintains Buy Rating	22-08-12	MT
Jefferies Downgrades Aveanna Healthcare Holdings to Hold From Buy, Adjusts Price Target to $2.50 From $9	22-07-22	MT
RBC Cuts Price Target on Aveanna Healthcare Holdings to $7 From $9 After Q2 Warning Amid Labor Issues; Outperform Kept	22-07-20	MT
Truist Securities Downgrades Aveanna Healthcare Holdings to Hold From Buy	22-07-05	MT
BofA Securities Downgrades Aveanna Healthcare Holdings to Underperform From Neutral, Adjusts Price Target to $2 From $3	22-06-21	MT
Stephens Cuts Aveanna Healthcare Holdings to Equalweight From Overweight, Price Target to $3.50 From $5.50	22-06-21	MT
BofA Securities Adjusts Aveanna Healthcare Holdings Price Target to $3 From $3.50, Maintains Neutral Rating	22-06-15	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.16 USD

Average target price

2.57 USD

Spread / Average Target

+18.98%

High Price Target

3 USD

Spread / Highest target

+38.89%

Low Price Target

1.6 USD

Spread / Lowest Target

-25.93%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Aveanna Healthcare Holdings Inc.

Deutsche Bank Securities
JPMorgan Chase
UBS
RBC Capital Markets
Truist Securities
Raymond James
Credit Suisse
Stephens Inc.
Barclays
Jefferies & Co.
BofA Securities
BMO Capital
J.P. Morgan Chase

Ratings for Aveanna Healthcare Holdings Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar